Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: A cross-sectional study

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Cailhol, Johann ^a,b   Nkurunziza, Béatrice ^b   Izzedine, Hassan ^c   Nindagiye, Emmanuel ^b   Munyana, Laurence ^d   Baramperanye, Evelyne ^e   Nzorijana, Janvière ^f   Sakubu, Désiré ^g   Niyongabo, Théodore ^b,d   Bouchaud, Olivier ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b National Centre for HIV Reference   (Burundi)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Bujumbura University Hospital   (Burundi)

^e Association Nationale de Soutien Aux Séropositifs ANSS   (Burundi)

^f Department of Medicine   (Burundi)

^g Nouvelle Espérance ^*  (Burundi)

Author keywords

aseptic leukocyturia; chronic kidney disease; kidney damage; prevalence; proteinuria; risk factors

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; CD4 ANTIGEN; COTRIMOXAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT;

4 VARIABLE MODIFICATION OF DIET IN RENAL DISEASE; ADULT; AGE; AIDS PATIENT; ARTICLE; BODY MASS; BURUNDI; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COCKROFT GAULT ESTIMATION METHOD; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LEUKOCYTURIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL KIDNEY FOUNDATION DEFINITION; PROTEINURIA; RISK FACTOR; TUBERCULOSIS; UROGENITAL TRACT MALFORMATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BURUNDI; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE;

EID: 80052024581     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-40     Document Type: Article

References (34)

1. Kidney disease in patients with HIV infection and AIDS. Winston J, Deray G, Hawkins T, et al. Clin Infect Dis 2008 47 11 1449 57 10.1086/593099 18947327
2. HIV-associated nephropathy. Ross MJ, Klotman PE, AIDS (London, England) 2004 18 8 1089 99 10.1097/00002030-200405210-00002 (Pubitemid 38738508)
3. Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell. Wools-Kaloustian KK, Gupta SK, Kidney Int 2008 74 7 845 7 10.1038/ki.2008.326 18794814
4. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. Lucas GM, Lau B, Atta MG, et al. J Infect Dis 2008 197 11 1548 57 10.1086/587994 18422458 (Pubitemid 351706485)
5. HIV and the kidney: a spotlight on racial disparities. Wyatt CM, J Infect Dis 2008 197 11 1490 2 10.1086/587995 18422454 (Pubitemid 351706476)
6. The renal complications of HIV. Allison SJ, Nature Rev 2009 5 10 545
7. HIV and kidney disease in sub-Saharan Africa. Fabian J, Naicker S, Nature Rev 2009 5 10 591 8
8. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Emem CP, Arogundade F, Sanusi A, et al. Nephrol Dial Transplant 2008 23 2 741 6 18065807 (Pubitemid 351767653)
9. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Han TM, Naicker S, Ramdial PK, et al. Kidney Int 2006 69 12 2243 50 10.1038/sj.ki.5000339 16672914 (Pubitemid 43882112)
10. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Peters PJ, Moore DM, Mermin J, et al. Kidney Int 2008 74 7 925 9 10.1038/ki.2008.305 18614998
11. Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Wools-Kaloustian K, Gupta SK, Muloma E, et al. Nephrol Dial Transplant 2007 22 8 2208 12 10.1093/ndt/gfm223 17652119 (Pubitemid 47248464)
12. Prevalence Of Renal Disease In Patients Attending The HIV/AIDS Clinic, At Mbarara University Teaching Hospital. Andia I, Pepper L, Matheison P, The 3rd IAS Conference on HIV Pathogenesis and Treatment 2005
13. Renal dysfunction and HIV associated nephropathy (HIVAN) in Nigerians: prevalence, clinical features and histopathology. Arogundade F, Emem-Chioma P, Sanusi A, et al. XVI International AIDS Conference 2006
14. Renal disease in an antiretroviral nave HIV-infected population in western Kenya. Muloma E, Owino-Ong'or W, Sidle J, et al. The 3rd IAS Conference on HIV Pathogenesis and Treatment 2005
15. Evaluation, Classification, and Stratification. Clinical Practice Guidelines for Chronic Kidney Disease, National Kidney Foundation KDOQI GUIDELINES 2002 http://www.kidney.org/professionals/KDOQI/guidelines-ckd/p4- class.htm cited 2009 10 October
16. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Levey AS, Bosch JP, Lewis JB, et al. Ann Int Med 1999 130 6 461 70 10075613 (Pubitemid 29135798)
17. A formula to estimate the approximate surface area if height and weight be known. Dubois D, Dubois EF, Arch Int Med 1916 17 863 71
18. Absence of HIV-associated nephropathy in Ethiopians. Behar DM, Shlush LI, Maor C, et al. Am J Kidney Dis 2006 47 1 88 94 10.1053/j.ajkd.2005.09.023 16377389 (Pubitemid 41828270)
19. Prevalence of chronic kidney disease in an urban HIV infected population. Fernando SK, Finkelstein FO, Moore BA, et al. Am J Med Sci 2008 335 2 89 94 10.1097/MAJ.0b013e31812e6b34 18277114 (Pubitemid 351253402)
20. Chronic kidney disease prevalence and risk factors among HIV-infected patients. Sorli ML, Guelar A, Montero M, et al. Journal Acquir Immune Defic Syndr (1999) 2008 48 4 506 8 10.1097/QAI.0b013e31817bbecb
21. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. Overton ET, Nurutdinova D, Freeman J, et al. HIV Med 2009 10 6 343 50 10.1111/j.1468-1293. 2009.00693.x 19490182
22. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. Kalayjian RC, Franceschini N, Gupta SK, et al. AIDS (London, England) 2008 22 4 481 7 10.1097/QAD.0b013e3282f4706d (Pubitemid 351317289)
23. Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. Stohr W, Walker AS, Munderi P, DART Trial, et al. Antivir Ther 2008 13 6 761 70 18839777
24. Genitourinary tuberculosis in a medical center in southern Taiwan: an eleven-year experience. Hsieh HC, Lu PL, Chen YH, et al. J Microbiol Immunol Infect 2006 39 5 408 13 17066204
25. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Whelton A, Am J Med 1999 106 5B 13S 24S 10390124 (Pubitemid 29268660)
26. Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management-a single-center study in South Africa. Fabian J, Naicker S, Venter WDF, et al. Ethn Dis 2009 19 S1 80 5 19348014
27. Predictors of proteinuria and renal failure among women with HIV infection. Szczech LA, Gange SJ, van der Horst C, et al. Kidney Int 2002 61 1 195 202 10.1046/j.1523-1755.2002.00094.x 11786101 (Pubitemid 34075147)
28. Recent progress in HIV-associated nephropathy. Ross MJ, Klotman PE, J Am Soc Nephrol 2002 13 12 2997 3004 10.1097/01.ASN.0000040750.40907.99 12444220 (Pubitemid 35386920)
29. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Wyatt CM, Morgello S, Katz-Malamed R, et al. Kidney Int 2009 75 4 428 34 10.1038/ki.2008.604 19052538
30. Comparison and agreement of the Cockroft-Gault and MDRD equaltions to estimate glomerular filtration rate in diagnosis of occult kidney disease. Buitrago F, Calvo JI, Gomez-Jimenez C, et al. Nefrologia 2008 28 3 301 10 18590497
31. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. WHO, Geneva: World Health Organization 2009
32. Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia. Chi BH, Mwango A, Giganti M, et al. Journal Acquir Immune Defic Syndr 1999 54 1 63 70
33. The 3-year safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretrovral-naive patients. Gallant JE, Winston J, DeJesus E, et al. AIDS (London, England) 2008 22 2155 63 10.1097/QAD.0b013e3283112b8e
34. Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. Wever K, van Agtmael MA, Carr A, Journal Acquir Immune Defic Syndr 1999 55 1 78 81